Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis

被引:53
作者
Hirst, C. [1 ]
Ingram, G. [1 ]
Swingler, R. [2 ]
Compston, D. A. S. [3 ]
Pickersgill, T. [1 ]
Robertson, N. P. [1 ]
机构
[1] Univ Wales Hosp, Helen Durham Neuroinflammatory Ctr, Dept Neurol, Cardiff CF14 4XN, S Glam, Wales
[2] Ninewells Hosp, Dept Neurol, Dundee DD1 9SY, Scotland
[3] Univ Cambridge, Sch Clin, Dept Clin Neurosci, Addenbrookes Hosp, Cambridge CB2 0QQ, England
关键词
D O I
10.1136/jnnp.2007.133785
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: In patients with multiple sclerosis (MS), the natural history of the disease is of considerable importance to predict and understand long- term outcome and inform choices made by patients and clinicians. This information should ideally be derived from data that reflects the entire disease course. Methods: In this study, morbidity data from a prevalent cohort established in 1985 have been re-examined after an interval of 20 years to assess factors that may be important in determining outcome. Results: Of 379 patients who fulfilled criteria for definite or probable MS in the original population-based cohort, 221 (58.3%) had died, 149 (39.3%) were alive and 9 (2.4%) were untraceable. Mean Expanded Disability Status Scale (EDSS) score in 1985 was 5.15 (SD 2.7, range 0-9.5) and 8.01 (SD 2.6, range 0-10) in those alive in 2005. Mean worsening of EDSS scores in surviving patients was +3.02 EDSS points, but 14.0% had worsened by,1 EDSS point over 20 years. 61.4% of patients with EDSS 3.5-5.5 and 82.2% of those with an EDSS of (3 in 1985 had an EDSS of >= 6 after 20 years. Lower baseline EDSS scores (p < 0.0001), higher pyramidal functional system score (p = 0.02) and a greater number of functional systems involved (p = 0.001) were significantly more likely to be associated with greater worsening of disability. Of those with benign disease in 1985, only 19% remained benign after 20 years of follow-up; however, 12.6% of patients had minimal disability after at least 20 years after their disease onset and 14% of patients failed to worsen by >= 1 EDSS point. Conclusions: This study emphasises the importance of long- term epidemiological studies and the development of clinically relevant measures that effectively predict outcome and can guide decisions on therapeutic management.
引用
收藏
页码:1137 / 1143
页数:7
相关论文
共 46 条
[1]   SURVIVAL IN DISSEMINATED SCLEROSIS - A CLINICAL STUDY OF A SERIES OF CASES 1ST SEEN 20 YEARS AGO [J].
ALLISON, RS .
BRAIN, 1950, 73 (01) :103-115
[2]   A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials [J].
Amato, MP ;
Ponziani, G ;
Bartolozzi, ML ;
Siracusa, G .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 168 (02) :96-106
[3]   The natural history of untreated multiple sclerosis in Iceland.: A total population-based 50 year prospective study [J].
Benedikz, J ;
Stefánsson, M ;
Guomundsson, J ;
Jónasdóttir, A ;
Fossdal, R ;
Gulcher, J ;
Stefánsson, K .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2002, 104 (03) :208-210
[4]   Disability and mortality in a cohort of multiple sclerosis patients: A reappraisal [J].
Bergamaschi, R ;
Montomoli, C ;
Candeloro, E ;
Fratti, C ;
Citterio, A ;
Cosi, V .
NEUROEPIDEMIOLOGY, 2005, 25 (01) :15-18
[5]   Trends in survival and cause of death in Danish patients with multiple sclerosis [J].
Bronnum-Hansen, H ;
Koch-Henriksen, N ;
Stenager, E .
BRAIN, 2004, 127 :844-850
[6]   SURVIVAL OF PATIENTS WITH MULTIPLE-SCLEROSIS IN DENMARK - A NATIONWIDE, LONG-TERM EPIDEMIOLOGIC SURVEY [J].
BRONNUMHANSEN, H ;
KOCHHENRIKSEN, N ;
HYLLESTED, K .
NEUROLOGY, 1994, 44 (10) :1901-1907
[7]   MULTIPLE-SCLEROSIS - DISABILITY AND MORTALITY IN A COHORT OF CLINICALLY DIAGNOSED PATIENTS [J].
CITTERIO, A ;
AZAN, G ;
BERGAMASCHI, R ;
ERBETTA, A ;
COSI, V .
NEUROEPIDEMIOLOGY, 1989, 8 (05) :249-253
[8]   The window of therapeutic opportunity in multiple sclerosis [J].
Coles, AJ ;
Cox, A ;
Le Page, E ;
Jones, J ;
Trip, SA ;
Deans, J ;
Seaman, S ;
Miller, DH ;
Hale, G ;
Waldmann, H ;
Compston, DA .
JOURNAL OF NEUROLOGY, 2006, 253 (01) :98-108
[9]   Accumulation of irreversible disability in multiple sclerosis: From epidemiology to treatment [J].
Confavreux, C ;
Vukusic, S .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2006, 108 (03) :327-332
[10]   Relapses and progression of disability in multiple sclerosis. [J].
Confavreux, C ;
Vukusic, S ;
Moreau, T ;
Adeleine, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (20) :1430-1438